Virax Biolabs Group Limited (VRAX)
USD 2.37
(39.41%)
USD 2.37
(39.41%)
| Breakdown | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Revenue | 156.41 Thousand | 8561.00 | - | 123.82 Thousand | 99.87 Thousand |
| Cost of Revenue | 105.82 Thousand | 9926.00 | - | 133.25 Thousand | 54.12 Thousand |
| Gross Profit | 50.59 Thousand | -1365.00 | - | -9434.00 | 45.74 Thousand |
| Operating Expenses | 6.54 Million | 5.73 Million | 1.73 Million | 635.1 Thousand | 696.99 Thousand |
| Selling, General and Administrative Expenses | 4.59 Million | 5.33 Million | 1.29 Million | 514.88 Thousand | 609.99 Thousand |
| Research and Development Expenses | 1.56 Million | 397.1 Thousand | 433.74 Thousand | 120.22 Thousand | 87 Thousand |
| Other Expenses | 390.35 Thousand | 290.46 Thousand | - | 266.00 | 2470.00 |
| Cost and Expenses | 6.65 Million | 5.74 Million | 1.73 Million | 768.35 Thousand | 751.12 Thousand |
| Operating Income | -6.49 Million | -5.73 Million | -1.73 Million | -644.54 Thousand | -651.24 Thousand |
| Interest Expense | 26.87 Thousand | 15.46 Thousand | 15.43 Thousand | 28.64 Thousand | 90.69 Thousand |
| Income Tax Expense | - | -271.00 | -1.77 Million | -666.46 Thousand | 61.66 Thousand |
| Earnings before Tax | -6.73 Million | -5.45 Million | -1.74 Million | -672.91 Thousand | -739.46 Thousand |
| Net Income | -6.73 Million | -5.45 Million | -1.7 Million | -650.98 Thousand | -801.13 Thousand |
| Earnings Per Share Basic | -3.36 | -5.13 | -1.50 | -0.57 | -0.70 |
| Earnings Per Share Diluted | -3.36 | -5.13 | -1.50 | -0.57 | -0.70 |
| Weighted Average Shares Outstanding | 2 Million | 1.06 Million | 1.13 Million | 1.13 Million | 1.13 Million |
| Weighted Average Shares Outstanding (Diluted) | 2 Million | 1.06 Million | 1.13 Million | 1.13 Million | 1.13 Million |
| Gross Margin | 0.32 | -0.16 | - | -0.08 | 0.46 |
| EBIT Margin | -42.25 | -669.64 | - | -5.21 | -6.50 |
| Profit Margin | -43.05 | -637.48 | - | -5.26 | -8.02 |
| EBITDA | -6.6 Million | -5.44 Million | -750.00 | - | -648.77 Thousand |
| Earnings Before Tax Margin | -41.53 | -669.64 | - | -5.21 | -6.52 |
| Breakdown | 2024 Q4 | 2024 FY | 2024 Q2 | 2023 Q4 | 2023 FY | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | 79.91 Thousand | 156.41 Thousand | 76.5 Thousand | 2801.00 | 8561.00 | 5760.00 |
| Cost of Revenue | 39.84 Thousand | 105.82 Thousand | 65.98 Thousand | 4284.00 | 9926.00 | 5642.00 |
| Gross Profit | 40.07 Thousand | 50.59 Thousand | 10.51 Thousand | -1483.00 | -1365.00 | 118.00 |
| Operating Expenses | 3.83 Million | 6.15 Million | 2.71 Million | 4.29 Million | 5.73 Million | 1.44 Million |
| Selling, General and Administrative Expenses | 2.28 Million | - | 2.3 Million | 3.99 Million | - | 1.34 Million |
| Research and Development Expenses | 1.15 Million | - | 409.29 Thousand | 300.48 Thousand | - | 96.62 Thousand |
| Other Expenses | 390.35 Thousand | -215.76 Thousand | - | - | 290.46 Thousand | - |
| Cost and Expenses | 3.87 Million | 6.26 Million | 2.78 Million | 4.29 Million | 5.74 Million | 1.44 Million |
| Operating Income | -3.79 Million | -6.49 Million | -2.7 Million | -4.29 Million | -5.73 Million | -1.44 Million |
| Interest Expense | 16.76 Thousand | 26.87 Thousand | 10.11 Thousand | 5860.00 | 15.46 Thousand | 9608.00 |
| Income Tax Expense | -1031.00 | -194.47 Thousand | -4551.00 | -4.28 Million | -271.00 | -1.45 Million |
| Earnings before Tax | -3.82 Million | -6.73 Million | -2.91 Million | -4 Million | -5.45 Million | -1.45 Million |
| Net Income | -3.82 Million | -6.73 Million | -2.9 Million | -4.01 Million | -5.45 Million | -1.44 Million |
| Earnings Per Share Basic | -1.71 | - | -1.64 | -2.58 | - | -1.24 |
| Earnings Per Share Diluted | -1.71 | - | -1.64 | -2.58 | - | -1.24 |
| Weighted Average Shares Outstanding | 2.23 Million | 1.77 Million | 1.77 Million | 1.55 Million | 1.06 Million | 1.16 Million |
| Weighted Average Shares Outstanding (Diluted) | 2.23 Million | 1.77 Million | 1.77 Million | 1.55 Million | 1.06 Million | 1.16 Million |
| Gross Margin | 0.50 | 0.32 | 0.14 | -0.53 | -0.16 | 0.02 |
| EBIT Margin | -41.91 | - | -35.14 | -1532.38 | - | -250.10 |
| Profit Margin | -47.85 | -43.05 | -38.03 | -1433.02 | -637.48 | -250.63 |
| EBITDA | -3.34 Million | - | -2.68 Million | -4.29 Million | - | -1.44 Million |
| Earnings Before Tax Margin | -47.43 | -41.53 | -35.38 | -1532.38 | -669.64 | -250.10 |
IHICY
7242
SGAMY
000633
6485
3191